title: Prolonged survival of a patient with papillary renal cell carcinoma and brain metastases using pazopanib.
authors: University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390-9133, USA.
authors: Corbin
authors: C
authors: Jacobs
authors: Dong Wook Nathan
authors: DW
authors: Kim
authors: Christopher
authors: C
authors: Straka
authors: Robert D
authors: RD
authors: Timmerman
authors: James
authors: J
authors: Brugarolas
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000556:secondary*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy / Q000556:secondary* / Q000601:surgery; D018450:Disease Progression; D004334:Drug Administration Schedule; D017809:Fatal Outcome; D006801:Humans; D007191:Indazoles; D007680:Kidney Neoplasms / Q000473:pathology* / Q000601:surgery; D008207:Lymphatic Metastasis; D008279:Magnetic Resonance Imaging; D008297:Male; D009392:Nephrectomy; D011743:Pyrimidines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D040262:Receptors, Vascular Endothelial Growth Factor / Q000037:antagonists & inhibitors; D013449:Sulfonamides / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D007191:Indazoles; D011743:Pyrimidines; D013449:Sulfonamides; C516667:pazopanib; D040262:Receptors, Vascular Endothelial Growth Factor